ALK-ABELLO A/S

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25230
 
  
 
C07K PEPTIDES 11125
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
A23J PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS 416
 
  
 
A61J CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 426
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 395
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0087,231 ALLERGEN FOR PROPHYLACTIC TREATMENT OF ALLERGYJun 04, 15Mar 30, 17[A61K]
2016/0194,725 MOLECULAR IDENTIFICATION OF ALLERGY CAUSING MITES BY PCRJul 16, 14Jul 07, 16[C12Q]
2016/0151,481 PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOFJan 08, 16Jun 02, 16[A61K]
2015/0126,459 PLANT PROFILIN POLYPEPTIDES FOR USE IN NON-SPECIFIC ALLERGY IMMUNOTHERAPYApr 16, 13May 07, 15[C07K]
2014/0206,027 METHOD FOR QUANTIFICATION OF ALLERGENSMar 05, 14Jul 24, 14[C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9657070 Recombinant allergenFeb 20, 13May 23, 17[A61K, C07K]
9415015 Allergen dosage formApr 04, 08Aug 16, 16[A61K, A61P]
9408805 Allergen dosage formMay 27, 14Aug 09, 16[A61K, A61P]
9265824 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereofJun 03, 11Feb 23, 16[A61K, A23J, C07K]
9259464 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereofDec 07, 11Feb 16, 16[A61K, A23J, C07K]
9259464 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereofDec 07, 11Feb 16, 16[A61K, A23J, C07K]
9248097 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen seasonApr 08, 09Feb 02, 16[A61K]
9155694 Stabilized composition comprising at least one adrenergic compoundJun 03, 10Oct 13, 15[A61K]
8703903 Method for quantification of allergensSep 01, 06Apr 22, 14[A61K, A23J, C07K]
8551491 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen productNov 12, 10Oct 08, 13[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0287,696 PAN POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATIONAbandonedNov 20, 14Oct 06, 16[A61K, C07K]
2016/0287,696 PAN POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATIONAbandonedNov 20, 14Oct 06, 16[A61K, C07K]
2014/0127,298 MUCOSOMAL ALLERGEN-SPECIFIC IMMUNOTHERAPY WITH INITIAL DOSING AFTER START OF POLLEN SEASONAbandonedJan 10, 14May 08, 14[A61K]
8628805 Stabilized composition comprising at least one adrenergic compoundExpiredJun 04, 10Jan 14, 14[A61K, A01N]
2014/0010,845 SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIALAbandonedOct 14, 11Jan 09, 14[A61K]
2013/0216,582 SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGENAbandonedOct 14, 11Aug 22, 13[A61K]
8491911 Pharmaceutical product for up-dosing of allergy vaccineExpiredOct 15, 09Jul 23, 13[A61K]
8492099 Method of measuring enzymatic activity of adsorbed allergenic enzymeExpiredNov 23, 06Jul 23, 13[G01N]
2013/0008,818 CONTAINER FOR A BLISTER PACKAGEAbandonedJun 12, 12Jan 10, 13[B65D]
8312841 Method for mite productionExpiredMar 28, 08Nov 20, 12[A01K]
2012/0141,536 USE OF AN ADJUVANTED ALLERGY VACCINE FORMULATION FOR PARENTERAL ADMINISTRATIONAbandonedMar 28, 08Jun 07, 12[A61K, A61P]
2012/0141,536 USE OF AN ADJUVANTED ALLERGY VACCINE FORMULATION FOR PARENTERAL ADMINISTRATIONAbandonedMar 28, 08Jun 07, 12[A61K, A61P]
2012/0100,163 SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGENAbandonedOct 14, 11Apr 26, 12[A61K, A61P]
2012/0100,164 SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIALAbandonedOct 14, 11Apr 26, 12[A61K, A61P]
8012505 Dosage form having a saccharide matrixExpiredFeb 23, 04Sep 06, 11[A61K]
2011/0200,641 MINOR ALLERGEN CONTROL TO INCREASE SAFETY OF IMMUNOTHERAPYAbandonedApr 21, 11Aug 18, 11[A61K, G01N, A61P]
2011/0200,641 MINOR ALLERGEN CONTROL TO INCREASE SAFETY OF IMMUNOTHERAPYAbandonedApr 21, 11Aug 18, 11[A61K, G01N, A61P]
7968351 Method for dissolution testing of pharmaceutical productsExpiredDec 22, 06Jun 28, 11[G01N]
2011/0052,639 ALLERGEN MUTANTSAbandonedJul 15, 10Mar 03, 11[A61K, A61P]
2010/0291,155 ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATIONAbandonedJan 07, 09Nov 18, 10[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.